What Shapes Psychologists’ Attitudes Toward Psychedelics? A Closer Look at the Data

As research on psychedelic-assisted therapy continues to grow, psychologists are likely to play a central role in delivering these treatments. But how do psychologists actually feel about psychedelics? And what factors shape their attitudes? 

A study titled Predictors of Attitudes Toward Psychedelics Among Psychologists in the USA explored these questions in depth. The research was led by Jason Luoma, PhD, Brian Pilecki, PhD, and Sarah M. Smith from Portland Psychotherapy, along with Alan K. Davis, PhD, from The Ohio State University. 

The findings reveal that psychologists are far from uniform in their views and that personal experience and knowledge matter more than many demographic variables. 

Why Clinician Attitudes Will Shape Access to Psychedelic Therapy 

Psychedelic-assisted therapy, including treatments involving psilocybin and MDMA, may become more widely available in the coming years. If that happens, psychologists will likely be among the professionals providing or referring for these treatments. 

However, stigma around psychedelics remains strong. National surveys show that many Americans believe psychedelics carry significant risks, even though clinical trials have reported relatively low rates of serious adverse events in controlled settings. 

Understanding psychologists’ attitudes is not just academic. Negative beliefs could influence referrals, treatment recommendations, or how openly clinicians discuss psychedelic experiences with the people they serve. 

How the Study Worked 

The study analyzed survey data from 366 licensed psychologists across the United States. Participants varied in age, region, theoretical orientation, religious affiliation, and level of experience. 

Researchers examined how several variables predicted overall attitudes toward psychedelics, including: 

• Age 

• Gender 

• Region of the country 

• Religious affiliation 

• Self-reported knowledge of psychedelic risks and benefits 

• Personal experience with psychedelics 

• Having friends or loved ones with positive psychedelic experiences 

• Training in addictions treatment 

Attitudes were measured using a combination of items assessing perceived safety, therapeutic potential, and agreement with statements about risks and legality. 

Five Predictors of Psychologist Attitudes 

1. Knowledge Was Strongly Linked to More Positive Attitudes 

Psychologists who reported greater knowledge about the risks and benefits of psychedelics tended to hold more favorable attitudes. 

This is important. It suggests that education may play a meaningful role in reducing stigma. When psychologists feel informed about both safety concerns and therapeutic evidence, they may develop more balanced views. 

2. Personal Experience Mattered 

Psychologists who had personally used psychedelics reported more positive attitudes compared to those who had not. Among those with prior experience, more positive experiences were associated with more favorable attitudes. 

In fact, personal experience accounted for a notable portion of the variation in attitudes. This aligns with what social psychologists call the “contact hypothesis,” which suggests that exposure to a stigmatized group or phenomenon can reduce negative bias. 

3. Knowing Someone With a Positive Experience Also Helped 

Having a friend or loved one who had a positive experience with psychedelics was one of the strongest predictors of favorable attitudes. 

Among psychologists who knew someone with a positive experience, the more transformative that experience was perceived to be, the more positive their own attitudes tended to be. 

This finding highlights the power of personal stories. Case examples and lived experiences may influence clinician attitudes in ways that abstract data alone cannot. 

4. Demographic Differences Were Present but Modest 

Some demographic patterns emerged: 

• Younger psychologists tended to report slightly more positive attitudes. 

• Psychologists in the West and Northeast reported more favorable views compared to those in the Midwest and South. 

• Men reported more positive attitudes than women. 

• Psychologists who were religiously unaffiliated reported more favorable views than those affiliated with organized religion. 

However, these effects were generally smaller than the influence of knowledge and personal or social exposure. 

5. Addictions Training Was Not a Predictor 

Interestingly, level of training in addictions treatment was not significantly associated with attitudes toward psychedelics. This suggests that specialized training in substance use treatment does not automatically translate into more positive or negative views of psychedelic therapies. 

What This Means for the Field 

This study makes one thing clear: psychologists are not monolithic in their views. Attitudes toward psychedelics vary based on experience, knowledge, and social exposure. 

The strong link between knowledge and positive attitudes suggests that education could reduce stigma and increase openness. Similarly, incorporating real-world case studies and client stories into professional education may help clinicians better understand both the risks and potential benefits of psychedelic-assisted therapy. 

The practical takeaway is concrete: as psychedelic-assisted therapy moves through regulatory processes, the field needs investment in clinician education — and in opportunities for clinicians to learn from people who have experienced these treatments firsthand. Both factors, more than demographics or theoretical orientation, look like the levers that will shape how widely and how responsibly these therapies are eventually offered. 

You can find the full article here. 

This article is for educational purposes and does not constitute medical advice or a recommendation to use psychedelic substances. Psychedelic-assisted therapy is currently available primarily through approved clinical trials and regulated programs such as Oregon’s psilocybin services.